Highland Capital Management (Tennessee)’s Novo Nordisk NVO Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$701K	Buy	14,618 +50	+0.3%	+$2.15K	0.03%	269
2026 Q1	$535K	Buy	14,568 +68	+0.5%	+$3.22K	0.03%	294
2025 Q4	$738K	Sell	14,500 -1,700	-10%	-$86.9K	0.04%	254
2025 Q3	$899K	Sell	16,200 -250	-2%	-$14.6K	0.04%	256
2025 Q2	$1.14M	Buy	16,450 +100	+0.6%	+$6.8K	0.06%	229
2025 Q1	$1.14M	Sell	16,350 -150	-0.9%	-$12.4K	0.07%	226
2024 Q4	$1.42M	Buy	16,500 +4,000	+32%	+$433K	0.08%	189
2024 Q3	$1.49M	Buy	+12,500	New	+$1.67M	0.08%	199

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Highland Capital Management (Tennessee)'s NVO Position: Q2 2026 in Review

Highland Capital Management (Tennessee) increased its Novo Nordisk (NVO) stake by 0.34% in Q2 2026, buying an estimated $2.15K and bringing the position to 14,618 shares worth $701K. The position accounts for 0.03% of the portfolio, ranked #269.

Highland Capital Management (Tennessee) first reported a position in NVO in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.49M in Q3 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Highland Capital Management (Tennessee) held 14,618 shares of Novo Nordisk worth $701K as of Q2 2026.
Highland Capital Management (Tennessee) bought 50 Novo Nordisk shares in Q2 2026, an estimated $2.15K.
Novo Nordisk made up 0.03% of Highland Capital Management (Tennessee)'s portfolio in Q2 2026, its #269 holding.
Highland Capital Management (Tennessee) first reported a position in Novo Nordisk in Q3 2024 and has held it in 8 quarters since.
Highland Capital Management (Tennessee)'s Novo Nordisk position peaked at $1.49M in Q3 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2026, filed 21 Jul 2026.